EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Does the duration of exposure to everolimus influence the occurrence of chronic lung allograft dysfunction?

Agathe Landoas, Quentin Perrier, Loïc Falque, Christel Saint-Raymond, Amandine Briault, Bruno Degano, Sébastien Chanoine, Pierrick Bedouch

Transplant Immunology · 2026

DOI: 10.1016/j.trim.2026.102436 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transplant Immunology, 2026. Verfasst von Agathe Landoas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Grenoble Alpes, Pharmacy Department, Grenoble Alpes University Hospital, Grenoble, France. Hauptthemen laut MEDLINE: Everolimus, Graft Rejection, Immunosuppressive Agents, Lung Transplantation. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Everolimus has been incorporated into the immunosuppressive management of lung transplant patients. Due to its anti-proliferative properties, it is being studied in the context of chronic lung allograft dysfunction (CLAD). This study aims to evaluate the factors involved in the occurrence of CLAD, as well as the effects of introducing everolimus. MATERIALS AND METHODS: A retrospective, single-center observational study was conducted. The population studied consisted of lung transplant patients between January 1, 2000, and August 2021, who were treated with everolimus during their follow-up. Clinical, paraclinical, and biological data were collected from the patients' medical records. RESULTS: The timing of everolimus introduction was identified as a risk factor for CLAD [OR 1.069, 95% CI: 1.017; 1.123], as well as the number of everolimus discontinuations [OR 12.660, 95% CI: 1.025; 156.329]. DISCUSSION: Our study suggests a beneficial role of everolimus in preventing CLAD, particularly when introduced early and with minimal treatment interruptions. Lung function stability was maintained in our lung transplant patients. CONCLUSION: The use of everolimus for the prevention of CLAD is encouraging. This therapeutic class demonstrates effectiveness as well as safety in long-term biological parameter outcomes in lung transplant patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EverolimusGraft RejectionImmunosuppressive AgentsLung TransplantationAdultFemaleHumansMaleMiddle AgedAllograftsChronic DiseaseFollow-Up StudiesRetrospective StudiesRisk FactorsTime Factors

Stichwörter der Autor:innen

Allograft rejectionChronic lung allograft dysfunctionEverolimusLung transplantationmTOR inhibitor

Substanzen

EverolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Univ. Grenoble Alpes, Pharmacy Department, Grenoble Alpes University Hospital, Grenoble, France.
  • Univ. Grenoble Alpes, INSERM U1055, Pharmacy Department, LBFA, Grenoble Alpes University Hospital, Grenoble, France. Electronic address: qperrier@chu-grenoble.fr.
  • Univ. Grenoble Alpes, Pneumology and Physiology Department, Grenoble Alpes University Hospital, Grenoble, France.
  • Univ. Grenoble Alpes, INSERM U1300, Pneumology and Physiology Department, Grenoble Alpes University Hospital, HP2, Grenoble, France.
  • Univ. Grenoble Alpes, CNRS, Pharmacy Department, TIMC, UMR5525, Grenoble Alpes University Hospital, Grenoble, France.

Zitieren

APA

Landoas, A., Perrier, Q., Falque, L., Saint-Raymond, C., Briault, A., Degano, B., Chanoine, S., & Bedouch, P. (2026). Does the duration of exposure to everolimus influence the occurrence of chronic lung allograft dysfunction?. Transplant Immunology. https://doi.org/10.1016/j.trim.2026.102436

Vancouver

Landoas A, Perrier Q, Falque L, Saint-Raymond C, Briault A, Degano B, et al. Does the duration of exposure to everolimus influence the occurrence of chronic lung allograft dysfunction?. Transplant Immunology. 2026. doi:10.1016/j.trim.2026.102436

BibTeX
@article{Landoas2026,
  author = {Landoas, Agathe and Perrier, Quentin and Falque, Loïc and Saint-Raymond, Christel and Briault, Amandine and Degano, Bruno and Chanoine, Sébastien and Bedouch, Pierrick},
  title = {Does the duration of exposure to everolimus influence the occurrence of chronic lung allograft dysfunction?},
  journal = {Transplant Immunology},
  year = {2026},
  doi = {10.1016/j.trim.2026.102436}
}
Kostenlos starten →